Brickell Biotech Equity 2025

Brickell Biotech Aktienanalyse

What does Brickell Biotech do?

Brickell Biotech Inc is a biopharmaceutical company that focuses on the development and marketing of innovative dermatology products. The company was founded in 2009 and is headquartered in Boulder, Colorado (USA), with branches in California and Singapore. The history of Brickell Biotech dates back to the 1960s when the company was originally founded under the name Brickell Research Inc. Over the following decades, the company specialized in biological research and conducted important research that forms the basis for today's product development. Brickell Biotech's business model is based on the creation of new and innovative therapies for the treatment of various dermatological diseases. In recent years, the company has entered into a number of important partnerships to accelerate its product development and strengthen its position in the industry. Brickell Biotech operates in two main areas: pharmaceuticals and cosmetic products. In the pharmaceuticals area, the company has a number of promising therapies in the pipeline that target the treatment of skin cancer, psoriasis, and other dermatological conditions. The company's flagship product is Sofpironium Bromide, a potential treatment for hyperhidrosis (excessive sweating). In the cosmetic products area, the company has developed a range of skincare products tailored to the needs of people with sensitive, dry, or aging skin. These products include moisturizers, cleansers, and anti-aging products, all made from high-quality ingredients. Brickell Biotech works closely with the scientific community to explore the latest developments and innovations in dermatology and the cosmetics industry. The company has also established a strong presence in the medical and research sectors by collaborating closely with leading universities and medical institutions worldwide. Overall, Brickell Biotech is a promising company in the biopharmaceutical and cosmetics industry, specializing in the development of new and innovative therapies for the treatment of skin conditions. With a strong pipeline of products and a dedicated leadership team, the company is expected to continue growing and establish itself as an important player in the industry. Brickell Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Brickell Biotech's Equity

Brickell Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Brickell Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Brickell Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Brickell Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Brickell Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Brickell Biotech stock

What is the equity of Brickell Biotech this year?

Brickell Biotech has equity of 7.19 M USD this year.

What was the equity of Brickell Biotech compared to the previous year?

The equity of Brickell Biotech has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Brickell Biotech?

A high equity is advantageous for investors of Brickell Biotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Brickell Biotech?

A low equity can be a risk for investors of Brickell Biotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Brickell Biotech affect the company?

An increase in equity of Brickell Biotech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Brickell Biotech affect the company?

A reduction in equity of Brickell Biotech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Brickell Biotech?

Some factors that can affect the equity of Brickell Biotech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Brickell Biotech so important for investors?

The equity of Brickell Biotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Brickell Biotech take to change the equity?

To change equity, Brickell Biotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Brickell Biotech pay?

Over the past 12 months, Brickell Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brickell Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Brickell Biotech?

The current dividend yield of Brickell Biotech is .

When does Brickell Biotech pay dividends?

Brickell Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Brickell Biotech?

Brickell Biotech paid dividends every year for the past 0 years.

What is the dividend of Brickell Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Brickell Biotech located?

Brickell Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Brickell Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Brickell Biotech from 7/20/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/20/2025.

When did Brickell Biotech pay the last dividend?

The last dividend was paid out on 7/20/2025.

What was the dividend of Brickell Biotech in the year 2024?

In the year 2024, Brickell Biotech distributed 0 USD as dividends.

In which currency does Brickell Biotech pay out the dividend?

The dividends of Brickell Biotech are distributed in USD.